Exenatide vs Upadacitinib

Exenatide vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Exenatide and Upadacitinib.

Mechanism of Action

Exenatide: Synthetic exendin-4 GLP-1 receptor agonist enhancing glucose-dependent insulin secretion.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Exenatide — 2.4 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Upadacitinib — C17H19F3N6O.

Molecular Weight: Upadacitinib — 380.3700 g/mol.

Type: Exenatide — Protein; Upadacitinib — Small molecule.